about
Public preferences for communicating personal genomic risk information: a focus group studyDoes personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.Validation of Questionnaire and Diary Measures of Time Outdoors Against an Objective Measure of Personal Ultraviolet Radiation Exposure.Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanomaThe melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviorsGP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative studyExploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative studyWho should access germline genome sequencing? A mixed methods study of patient viewsPatients' Views About Skin Self-examination After Treatment for Localized MelanomaRisk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers'There is a lot of good in knowing, but there is also a lot of downs': public views on ethical considerations in population genomic screening
P50
Q30830961-A7CD12A5-CA2D-4921-80EF-ABE8108CB1CFQ38719905-41C7A035-38C6-4CAE-91DE-7874E677F169Q40519097-D3773AD3-42F7-46CE-8B1B-C1BADE7B1FD4Q40527956-FE7563C2-E37A-42AB-B28A-65976A60D7B2Q49333335-16F3C52C-2E0D-4430-915D-4E74C928B367Q50052938-9659B89D-B468-41A5-82B3-A6A0E52E2D8AQ56889703-950F333A-3D4F-4B9C-87F5-976025F5A524Q56889714-E4C0AFBC-3D3F-4F13-B800-989CB3487169Q64234492-570E7A4D-474D-4186-BF0F-F005B5249987Q90723739-0B05583A-B282-4D98-A47A-9D0BA8F1BA1FQ91049763-CC26F198-4FF1-4E3A-A97B-B3A9D060F035Q92036121-62D6CCA4-B6DD-4DDF-85F2-AD4587EF9673Q92132004-2D7CE480-D1A0-42D5-83C6-686979185101Q92438439-4CC90F46-9D80-4AC7-B61C-0120522204B3Q95336985-E36EFA1E-88F0-439E-A66F-29B1E4113DB4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amelia K Smit
@ast
Amelia K Smit
@en
Amelia K Smit
@es
Amelia K Smit
@nl
type
label
Amelia K Smit
@ast
Amelia K Smit
@en
Amelia K Smit
@es
Amelia K Smit
@nl
prefLabel
Amelia K Smit
@ast
Amelia K Smit
@en
Amelia K Smit
@es
Amelia K Smit
@nl
P106
P1153
56819779000
P21
P31
P496
0000-0001-5712-220X